Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
Does the presence of bronchiectasis change your approach to a patient with otherwise well-controlled patient with RA?
Related Questions
Do you use the peri-operative management of biologics and DMARDs guidelines, which were mainly based on total hip and knee replacement surgeries, for all peri-operative surgical management?
Would you uptitrate methotrexate dosing when a patient flares on a TNFi and methotrexate 15 mg weekly?
Do you feel comfortable using Jak inhibitors in patients with a strong family history of CAD, but no other risk factors?
How would you approach a patient with seronegative RA and ILD?
How would you approach management of a patient who develops squamous cell skin cancer while on abatacept?
How do you approach the timing of DMARD initiation in patients with active RA who are on treatment for latent TB?
Do you combine methotrexate and leflunomide for the treatment of RA?
How do you approach treatment of a patient with active RA and a history of Lynch Syndrome?
If subdeltoid bursitis, bicipital tenosynovitis, and femoroacetabular synovitis are commonly present in PMR, why are they not included in the criteria for PMR and how are they differentiated from elderly onset RA where presentation is often atypical and more proximal?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
